China Issues Guidance To Promote Domestic Innovation And Facilitate Industry Consolidation
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Before the release of a new five-year plan, China's Ministry of Industry and Information Technology, the Ministry of Health and the State FDA jointly released new guidance Nov. 9 to expedite restructuring China's healthcare industry, a signal of the government's efforts to promote innovation and industry consolidation